Diagonal Therapeutics
Cambridge, Massachusetts, United States · Biotechnology, Health Care · 28 employees
Diagonal Therapeutics is a biotech company pioneering a new approach to discovering and developing agonist antibodies. The Company's DIAGONAL platform combines proprietary computational and experimental techniques to overcome historical challenges associated with agonist antibody drug discovery. Diagonal's emerging pipeline – discovered using the DIAGONAL platform – has the potential to deliver li
Funding history
- Series series b — $125.0M — Jan 2026
- Series series a — $128.0M — Apr 2024
Recent signals
- Jan 08, 2026: Raised $125.0M in Series series b
- Jul 08, 2025: Diagonal Therapeutics Appoints John Lee as Chief Medical Officer
- Apr 03, 2024: Raised $128.0M in Series series a
See plans & pricing → Track Diagonal Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.